CareDx CDNA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -3.9%-18.3pp | -8.1%-20.3pp | 16.7%+69.8pp | 13.5%+74.6pp | 14.4%+87.7pp | |
| Net margin | -2%-19.9pp | -5.6%-21.4pp | 19.7%+68.7pp | 17.1%+73.0pp | 17.9%+85.7pp | |
| Returns | ||||||
| Return on equity | -2.4%-21.9pp | -6.3%-22.7pp | 24.1%+70.0pp | 19.6%+69.2pp | 19.5%+74.7pp | |
| Return on invested capital | -5.6%-24.8pp | -11.1%-27.2pp | 26.2%+85.6pp | 18.8%+84.4pp | 19.2%+89.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.2× | 0.8×+0.1× | 0.8×+0.1× | 0.7×+0.1× | 0.7×+0.2× | |
| Liquidity | ||||||
| Current ratio | 3.4×-0.7× | 2.9×-1.1× | 3×-1.1× | 3.3×-0.8× | 4.1×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $5.90-14.0% | $5.69-14.9% | $5.79+12.1% | $6.03+18.9% | $6.86+38.5% | |
| Valuation | ||||||
| Market capitalization | $889.12M-9.6% | $968.99M-15.6% | $773.92M-53.0% | $1.05B+29.7% | $983.81M+79.4% | |
| Price / sales | 2.2×-0.7× | 2.6×-0.9× | 2.2×-3.1× | 3.1×+0.4× | 2.8×+0.8× | |
| Price / book | 2.8×+0.2× | 3.2×+0.2× | 2.5×-3.5× | 3.2×+0.1× | 2.6×+0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CareDx's profit margins?
- CareDx (CDNA) runs a 65.5% gross margin and a -3.9% operating margin, with a -2.0% net margin.
- Where do CareDx's ratios come from?
- Every ratio is computed from CareDx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
